Skip to main content

Table 4 Results of the Mixed model ANOVAs for effects of protocol (SMA vs DLPFC rTMS) and time (pre-intervention, post-intervention) on OCD, anxiety and depressive symptoms in pharmacoresistant OCD patients

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Measure Source df Mean square F p-value partial eta2
Y-BOCS Time 1,63 958.15 53.51 0.001 0.46
Protocol 1,63 132.82 1.70 0.197 0.01
Time*protocol 1,63 1.15 0.06 0.803 0.05
BAI Time 1,63 2727.96 34.90 0.001 0.36
Protocol 1,63 58.06 0.43 0.511 0.18
Time*protocol 1,63 73.49 0.94 0.336 0.01
BDI-II Time 1,63 1044.46 19.97 0.001 0.24
Protocol 1,63 119.65 1.01 0.318 0.02
Time*protocol 1,63 0.004 0.01 0.993 0.01
  1. Y-BOCS Yale-Brown Obsessive-Compulsive Scale, BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory. Significant results are highlighted (p ≤ 0.05) in bold